125 related articles for article (PubMed ID: 3091283)
21. Consumption of a buckwheat protein extract retards 7,12-dimethylbenz[alpha]anthracene-induced mammary carcinogenesis in rats.
Kayashita J; Shimaoka I; Nakajoh M; Kishida N; Kato N
Biosci Biotechnol Biochem; 1999 Oct; 63(10):1837-9. PubMed ID: 10586513
[TBL] [Abstract][Full Text] [Related]
22. Potential use of D-glucaric acid derivatives in cancer prevention.
Walaszek Z
Cancer Lett; 1990 Oct; 54(1-2):1-8. PubMed ID: 2208084
[TBL] [Abstract][Full Text] [Related]
23. [Anticarcinogenic effect of potassium salts of glucaric and glucuronic acid in induced models of cervical and esophageal tumors].
Bespalov VG; Aleksandrov VA
Vopr Onkol; 2012; 58(4):537-40. PubMed ID: 23607211
[TBL] [Abstract][Full Text] [Related]
24. Mechanism of growth inhibition of mammary carcinomas by glucarate and the glucarate: retinoid combination.
Webb TE; Abou-Issa H; Stromberg PC; Curley RC; Nguyen MH
Anticancer Res; 1993; 13(6A):2095-9. PubMed ID: 8297119
[TBL] [Abstract][Full Text] [Related]
25. Evidence that D-glucaro-1,4-lactone shortens the pharmacological action of drugs being disposed via the bile as glucuronides.
Marselos M; Dutton G; Hänninen O
Biochem Pharmacol; 1975 Oct; 24(20):1855-8. PubMed ID: 1191334
[No Abstract] [Full Text] [Related]
26. Anti-carcinogenic activity of d-limonene during the initiation and promotion/progression stages of DMBA-induced rat mammary carcinogenesis.
Elson CE; Maltzman TH; Boston JL; Tanner MA; Gould MN
Carcinogenesis; 1988 Feb; 9(2):331-2. PubMed ID: 3123086
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics relevant to the anti-carcinogenic and anti-tumor activities of glucarate and the synergistic combination of glucarate:retinoid in the rat.
Webb TE; Pham-Nguyen MH; Darby M; Hamme AT
Biochem Pharmacol; 1994 Apr; 47(9):1655-60. PubMed ID: 8185680
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of azoxymethane-induced rat colon carcinogenesis by potassium hydrogen D-glucarate.
Yoshimi N; Walaszek Z; Mori H; Hanausek M; Szemraj J; Slaga TJ
Int J Oncol; 2000 Jan; 16(1):43-8. PubMed ID: 10601547
[TBL] [Abstract][Full Text] [Related]
29. Role of estrogen and prolactin in stimulation of carcinogen-induced mammary tumor development by a high-fat diet.
Aylsworth CF; Van Vugt DA; Sylvester PW; Meites J
Cancer Res; 1984 Jul; 44(7):2835-40. PubMed ID: 6426788
[TBL] [Abstract][Full Text] [Related]
30. Preventive effect of D-glucarate against renal damage induced by kanamycin.
Furuno K; Matsubara S; Ando K; Suzuki S
J Antibiot (Tokyo); 1976 Sep; 29(9):950-3. PubMed ID: 993134
[TBL] [Abstract][Full Text] [Related]
31. Chemoprevention of mammary tumorigenesis by a combined regimen of selenium and vitamin A.
Ip C; Ip MM
Carcinogenesis; 1981; 2(9):915-8. PubMed ID: 6794926
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of 7,12-dimethylbenz(a)anthracene-induced tumors and DNA adduct formation in the mammary glands of female Sprague-Dawley rats by the synthetic organoselenium compound, 1,4-phenylenebis(methylene)selenocyanate.
el-Bayoumy K; Chae YH; Upadhyaya P; Meschter C; Cohen LA; Reddy BS
Cancer Res; 1992 May; 52(9):2402-7. PubMed ID: 1568209
[TBL] [Abstract][Full Text] [Related]
33. Effect of neonatal administration of sex steroids on 7,12-dimethylbenz[a]anthracene-induced mammary carcinoma and dysplasia in female Sprague-Dawley rats.
Yoshida H; Fukunishi R
Gan; 1978 Oct; 69(5):627-31. PubMed ID: 103769
[No Abstract] [Full Text] [Related]
34. Prophylaxis of mammary neoplasia by selenium supplementation in the initiation and promotion phases of chemical carcinogenesis.
Ip C
Cancer Res; 1981 Nov; 41(11 Pt 1):4386-90. PubMed ID: 6796257
[TBL] [Abstract][Full Text] [Related]
35. Suppression of 7,12-dimethylbenz[a]anthracene-induced mammary carcinogenesis by pre-initiation treatment of rats with beta-naphthoflavone coincides with decreased levels of the carcinogen-derived DNA adducts in the mammary gland.
Malejka-Giganti D; Bennett KK; Culp SJ; Beland FA; Shinozuka H; Bliss RL
Cancer Detect Prev; 2005; 29(4):338-47. PubMed ID: 16054776
[TBL] [Abstract][Full Text] [Related]
36. Effect of the prostaglandin synthetase inhibitor indomethacin on 7,12-dimethylbenz(a)anthracene-induced mammary tumorigenesis in rats fed different levels of fat.
Carter CA; Milholland RJ; Shea W; Ip MM
Cancer Res; 1983 Aug; 43(8):3559-62. PubMed ID: 6407750
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of 7,12-dimethylbenz(a)anthracene-induced rat mammary carcinogenesis by concomitant or postcarcinogen antioxidant exposure.
McCormick DL; Major N; Moon RC
Cancer Res; 1984 Jul; 44(7):2858-63. PubMed ID: 6426789
[TBL] [Abstract][Full Text] [Related]
38. Antitumour synergism between non-toxic dietary combinations of isotretinoin and glucarate.
Abou-Issa H; Koolemans-Beynen A; Meredith TA; Webb TE
Eur J Cancer; 1992; 28A(4-5):784-8. PubMed ID: 1388036
[TBL] [Abstract][Full Text] [Related]
39. Influence of dietary retinyl acetate on normal rat mammary gland development and on the enhancement of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumorigenesis by high levels of dietary fat.
Aylsworth CF; Cullum ME; Zile MH; Welsch CW
J Natl Cancer Inst; 1986 Feb; 76(2):339-45. PubMed ID: 3080638
[TBL] [Abstract][Full Text] [Related]
40. Promotion of 7,12-dimethylbenz[a]anthracene-induced mammary tumorigenesis by high dietary fat in the rat: possible role of intercellular communication.
Aylsworth CF; Jone C; Trosko JE; Meites J; Welsch CW
J Natl Cancer Inst; 1984 Mar; 72(3):637-45. PubMed ID: 6422115
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]